You just read:

Semnur Pharmaceuticals, Inc., Announces Successful Phase 1 / 2 Trial in Patients with Radicular Pain for Its Lead Product, SP-102

News provided by

Semnur Pharmaceuticals, Inc.

Jun 26, 2017, 07:00 ET